A Randomized, Placebo-Controlled, 3-way Crossover Study to Investigate the Pharmacodynamic Effects of ICA-105665 Using the Intradermal Capsaicin and UV-B Models in Healthy Male Subjects.

Trial Profile

A Randomized, Placebo-Controlled, 3-way Crossover Study to Investigate the Pharmacodynamic Effects of ICA-105665 Using the Intradermal Capsaicin and UV-B Models in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Ibuprofen; ICA 105665
  • Indications Pain
  • Focus Pharmacodynamics
  • Sponsors Neusentis
  • Most Recent Events

    • 07 Jul 2011 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
    • 04 Mar 2010 Status changed from recruiting to completed, according to an Icagen media release.
    • 04 Mar 2010 Results were reported in a Icagen media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top